whether Fosamax (alendronate) and similar osteoporosis meds increase the risk of heart rate changes
June 2008
See FDA's updated safety analysis concerning bisphophonates and atrial fibrillation
You'll hear patients asking whether Fosamax (alendronate) and similar osteoporosis meds increase the risk of heart rate changes.
This first came up last year when researchers noted changes in heart rate in patients getting a related drug...zoledronic acid (Reclast).
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote